Lipid-core-peptide system for self-adjuvanting synthetic vaccine delivery

Methods in Molecular Biology

Volumn 751, Issue , 2011, Pages 297-308

  Skwarczynski, Mariusz ^a   Toth, Istvan ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Adjuvant; Boc solid phase peptide synthesis; Lipid core peptide; Lipoamino acids; Multiple antigenic peptide; Synthetic vaccine

Indexed keywords

AMINO ACID; DRUG CARRIER; EPITOPE; LAURIC ACID; LIPID CORE PEPTIDE; PEPTIDE; STREPTOCOCCUS VACCINE; UNCLASSIFIED DRUG; [(TERT BUTOXYCARBONYL)AMINO]DODECANOIC ACID; IMMUNOLOGICAL ADJUVANT; LAURIC ACID DERIVATIVE; LIPID; RECOMBINANT VACCINE;

ADJUVANT THERAPY; CLINICAL ASSESSMENT; DRUG DELIVERY SYSTEM; DRUG SYNTHESIS; GROUP A STREPTOCOCCAL INFECTION; IMMUNOGENICITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PEPTIDE SYNTHESIS; STREPTOCOCCUS GROUP A; VACCINATION; AMINO ACID SEQUENCE; ARTICLE; CHEMISTRY; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; SYNTHESIS;

ADJUVANTS, IMMUNOLOGIC; AMINO ACID SEQUENCE; DRUG DELIVERY SYSTEMS; EPITOPES; LAURIC ACIDS; LIPIDS; MOLECULAR SEQUENCE DATA; PEPTIDES; VACCINES, SYNTHETIC;

EID: 80053299814     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-61779-151-2_18     Document Type: Chapter

References (18)

1. Zhong, W., Skwarczynski, M., and Toth, I. (2009) Lipid Core Peptide System for Gene, Drug, and Vaccine Delivery, Aust. J. Chem. 62, 956-967.
2. Moyle, P. M., and Toth, I. (2008) Selfadjuvanting lipopeptide vaccines, Curr. Med. Chem. 15, 506-516.
3. Zhong, W., Skwarczynski, M., Fujita, Y., Simerska, P., Good, M. F., and Toth, I. (2009) Design and Synthesis of Lipopeptide-Carbohydrate Assembled Multivalent Vaccine Candidates Using Native Chemical Ligation, Aust. J. Chem. 62, 993-999.
4. Zhong, W., Skwarczynski, M., Simerska, P., Good, M. F., and Toth, I. (2009) Development of highly pure alpha-helical lipoglycopeptides as self-adjuvanting vaccines, Tetrahedron 65, 3459-3464.
5. Fujita, Y., Moyle, P. M., Hieu, S., Simerska, P., and Toth, I. (2008) Investigation toward multi-epitope vaccine candidates using native chemical ligation, Biopolymers 90, 624-632.
6. Moyle, P. M., Olive, C., Ho, M. F., Good, M. F., and Toth, I. (2006) Synthesis of a highly pure lipid core peptide based self-adjuvanting triepitopic group A Streptococcal vaccine, and subsequent immunological evaluation, J. Med. Chem. 49, 6364-6370.
7. Simerska, P., Abdel-Aal, A. B. M., Fujita, Y., Moyle, P. M., McGeary, R. P., Batzloff, M. R., Olive, C., Good, M. F., and Toth, I. (2008) Development of a liposaccharide-based delivery system and its application to the design of group a streptococcal vaccines, J. Med. Chem. 51, 1447-1452.
8. Moyle, P. M., Olive, C., Karpati, L., Barozzi, N., Ho, M. F., Dyer, J., Sun, H. K., Good, M., and Toth, I. (2005) Synthesis and immunological evaluation of M protein targeted tetra-valent and tri-valent group A streptococcal vaccine candidates based on the lipid-core peptide system, Int. J. Pept. Res. Ther. 12, 317-326.
9. Hayman, W. A., Toth, I., Flinn, N., Scanlon, M., and Good, M. F. (2002) Enhancing the immunogenicity and modulating the fine epitope recognition of antisera to a helical group A streptococcal peptide vaccine candidate from the M protein using lipid-core peptide technology, Immunol. Cell Biol. 80, 178-187.
10. Abdel-Aal, A. B. M., Batzloff, M. R., Fujita, Y., Barozzi, N., Faria, A., Simerska, P., Moyle, P. M., Good, M. F., and Toth, I. (2008) Structureactivity relationship of a series of synthetic lipopeptide self-adjuvanting group A streptococcal vaccine candidates, J. Med. Chem. 51, 167-172.
11. Olive, C., Hsien, K., Horvath, A., Clair, T., Yarwood, P., Toth, I., and Good, M. F. (2004) Protection against group A streptococcal infection by vaccination with self-adjuvanting lipid core M protein peptides, Vaccine 23, 2298-2303.
12. Olive, C., Batzloff, M. R., Horvath, A., Wong, A., Clair, T., Yarwood, P., Toth, I., and Good, M. F. (2002) A lipid core peptide construct containing a conserved region determinant of the group a streptococcal M protein elicits heterologous opsonic antibodies, Infect. Immun. 70, 2734-2738.
13. Horvath, A., Olive, C., Wong, A., Clair, T., Yarwood, P., Good, M., and Toth, I. (2002) A lipophilic adjuvant carrier system for antigenic peptides, Lett. Pept. Sci. 8, 285-288.
14. Cemazar, M., and Craik, D. J. (2008) Microwave-assisted Boc-solid phase peptide synthesis of cyclic cysteine-rich peptides, J. Pept. Sci. 14, 683-689.
15. Gibbons, W. A., Hughes, R. A., Charalambous, M., Christodoulou, M., Szeto, A., Aulabaugh, A. E., Mascagni, P., and Toth, I. (1990) Lipidic peptides. 1. Synthesis, resolution and structural elucidation of lipidic amino-acids and their homo-oligomers and heterooligomers, Liebigs Ann. Chem., 1175-1183.
16. Schnolzer, M., Alewood, P., Jones, A., Alewood, D., and Kent, S. B. H. (2007) In situ neutralization in boc-chemistry solid phase peptide synthesis - Rapid, high yield assembly of difficult sequences, Int. J. Pept. Res. Ther. 13, 31-44.
17. Schnolzer, M., Alewood, P., Jones, A., Alewood, D., and Kent, S. B. H. (1992) In situ neutralization in boc-chemistry solid phase peptide synthesis - Rapid, high yield assembly of difficult sequences, Int. J. Pept. Protein Res. 40, 180-193.
18. Sarin, V. K., Kent, S. B. H., Tam, J. P., and Merrifield, R. B. (1981) Quantitative monitoring of solid phase peptide-synthesis by the ninhydrin reaction, Anal. Biochem. 117, 147-157.